Decoy receptor 3 (DcR3) modulates resistance to platinum in epithelial ovarian cancer via Heparan Sulfate Proteoglycans (HSPGs).

被引：0
|
作者：
Connor, Joseph [1 ]
Felder, Mildred [1 ]
Patankar, Manish [1 ]
机构：
[1] Univ Wisconsin, Madison, WI USA
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2958
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Decoy receptor 3 (DcR3) modulates resistance to platinum in epithelial ovarian cancer via Heparan Sulfate Proteoglycans (HSPGs)
    Connor, Joseph
    Felder, Mildred
    Patankar, Manish
    CANCER RESEARCH, 2009, 69
  • [2] DcR3 binds to ovarian cancer via heparan sulfate proteoglycans and modulates tumor cells response to platinum with corresponding alteration in the expression of BRCA1
    Joseph P Connor
    Mildred Felder
    Arvinder Kapur
    Nonyem Onujiogu
    BMC Cancer, 12
  • [3] DcR3 binds to ovarian cancer via heparan sulfate proteoglycans and modulates tumor cells response to platinum with corresponding alteration in the expression of BRCA1
    Connor, Joseph P.
    Felder, Mildred
    Kapur, Arvinder
    Onujiogu, Nonyem
    BMC CANCER, 2012, 12
  • [4] Ascites from epithelial ovarian cancer contain high levels of functional decoy receptor 3 (DcR3) and is associated with platinum resistance
    Connor, Joseph P.
    Felder, Mildred
    GYNECOLOGIC ONCOLOGY, 2008, 111 (02) : 330 - 335
  • [5] Ascites from epithelial ovarian cancer contains high levels of functional decoy receptor 3 (DcR3) and is associated with platinum resistance and poor patient outcome
    Connor, J.
    Felder, M.
    GYNECOLOGIC ONCOLOGY, 2008, 111 (02) : 384 - 385
  • [6] Decoy receptor 3 (DcR3), a pleiotropic immunomodulator - Response
    Hsieh, Shie-Liang
    BLOOD, 2008, 112 (03) : 916 - 917
  • [7] Apoptosis of dendritic cells induced by decoy receptor 3 (DcR3)
    You, Ren-In
    Chang, Yung-Chi
    Chen, Po-Min
    Wang, Wei-Shu
    Hsu, Tsui-Ling
    Yang, Chih-Ya
    Lee, Chun-Ting
    Hsieh, Shie-Liang
    BLOOD, 2008, 111 (03) : 1480 - 1488
  • [8] Association of ascites and serum decoy receptor 3 (DCR3) levels with tumor infiltrating lymphocytes (TILS) and tumor vessels counts in epithelial ovarian cancer
    Bradford, L.
    Ziebarth, A.
    Felder, M.
    Connor, J.
    Harter, J.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : 598 - 598
  • [9] Quantification and detection of DcR3, a decoy receptor in TNFR family
    Chen, JG
    Zhang, LR
    Kim, S
    JOURNAL OF IMMUNOLOGICAL METHODS, 2004, 285 (01) : 63 - 70
  • [10] Decoy receptor 3 (DcR3) inhibits intratumoral lymphocytic infiltration by inhibiting LIGHT induced chemokine production in ovarian cancer
    Onujiogu, N.
    Felder, M.
    Kapur, A.
    Ziebarth, A.
    Connor, J.
    GYNECOLOGIC ONCOLOGY, 2012, 125 : S97 - S97
12345